Revolution Medicines (RVMD) Q3 2026 Earnings

5AugConfirmed
Q2 2025
Q4 2025
Q2 2026
Q3 2026
-3.06
-2.39
-1.72
-1.05

Details

Expected EPS
-2.042573
Actual EPS
-3.06
Surprise EPS
-1.02
Surprise Percent
+49.81%

Description

Revolution Medicines (RVMD) has reported earnings of -3.06 per share for Q3 2026.

0 Comments

Share your thoughts